ImmunologybioRxiv
Neutralizing and protective human monoclonal antibodies recognizing the N-terminaldomain of the SARS-CoV-2 spike protein
N. Suryadevara, S. Shrihari, P. Gilchuk…·J. E. Crowe
The paper identifies two NTD-specific human mAbs with neutralizing activity against SARS-CoV-2 and shows they require Fc effector functions for optimal protection.
DOI 10.1016/j.cell.2021.03.029